Design Therapeutics, Inc. (Nasdaq:DSGN)
Health Care/Life Sciences • Biotechnology
CIK 1807120
Company
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
Address
6005 Hidden Valley Road
Suite 110
Carlsbad, California 92011
6005 Hidden Valley Road
Suite 110
Carlsbad, California 92011
Employees
132
132
Stock Info
Close
$2.8800
$2.8800
Day Range
2.7300 - 2.9900
2.7300 - 2.9900
52 Week Range
1.9400 - 8.4700
1.9400 - 8.4700
Average volume
278.69K
278.69K
Short Interest
2.82M (02/15/24)
2.82M (02/15/24)
% of Float Shorted
8.67%
8.67%
Market Cap
$155.13M
$155.13M
Revenue
N/A
N/A
Net Income
-$63.31M
-$63.31M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Executive Chairman, President, CEO & CFO Pratik Shah PhD, MBA |
Independent Director Heather Behanna PhD |
Independent Director Deepa Prasad MBA |
Independent Director Arsani Hany William MD, MBA |
Independent Director John P Schmid MBA |
Independent Director Rodney W Lappe PhD |
Lead Independent Director Simeon J George MD, MBA |
Independent Director Stella Xu PhD |
SEC filings
Date | Form | Event |
---|---|---|
19 Dec, 2024 | 4 | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
13 Aug, 2024 | SC 13D/A | |
12 Aug, 2024 | 4 | |
9 Aug, 2024 | 144 | |
5 Aug, 2024 | 10-Q | |
5 Aug, 2024 | 8-K | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 8-K | |
17 Jun, 2024 | 4 | |
17 Jun, 2024 | 4 | |
8 May, 2024 | 10-Q | |
8 May, 2024 | 8-K | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | ARS | |
25 Mar, 2024 | 4 | |
25 Mar, 2024 | 4 | |
20 Mar, 2024 | 3 | |
19 Mar, 2024 | 8-K | |
19 Mar, 2024 | S-8 | |
19 Mar, 2024 | 10-K | |
14 Feb, 2024 | SC 13G/A | |
14 Feb, 2024 | SC 13G/A | |
23 Jan, 2024 | SC 13G/A | |
5 Jan, 2024 | 4 | |
5 Jan, 2024 | 4 | |
5 Dec, 2023 | 4 | |
5 Dec, 2023 | 4 | |
14 Nov, 2023 | SC 13G/A | |
13 Nov, 2023 | 10-Q | |
13 Nov, 2023 | 8-K | |
2 Oct, 2023 | 4 | |
7 Sep, 2023 | SC 13G/A | |
6 Sep, 2023 | 4/A | |
5 Sep, 2023 | 4 | |
30 Aug, 2023 | 4 | |
30 Aug, 2023 | 4 | |
25 Aug, 2023 | 8-K | CEO Change |
14 Aug, 2023 | 10-Q | |
14 Aug, 2023 | 8-K | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
2 Jun, 2023 | 4 | |
1 Jun, 2023 | 8-K | |
9 May, 2023 | 8-K | |
9 May, 2023 | 10-Q | |
13 Apr, 2023 | DEFA14A | |
13 Apr, 2023 | DEF 14A | |
13 Apr, 2023 | ARS | |
3 Apr, 2023 | SC 13G | |
14 Mar, 2023 | 8-K | |
14 Mar, 2023 | S-8 | |
14 Mar, 2023 | 10-K | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
8 Feb, 2023 | SC 13G | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | SC 13G | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
22 Dec, 2022 | SC 13G | |
22 Dec, 2022 | SC 13D/A | |
21 Dec, 2022 | 4 | |
20 Dec, 2022 | 4 | |
20 Dec, 2022 | 4 | |
12 Dec, 2022 | 4 | |
3 Nov, 2022 | 8-K | |
3 Nov, 2022 | 10-Q | |
13 Oct, 2022 | SC 13G | |
8 Aug, 2022 | 10-Q | |
8 Aug, 2022 | 8-K | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 8-K | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
16 Jun, 2022 | 4 | |
9 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
9 May, 2022 | EFFECT | |
5 May, 2022 | CORRESP | |
2 May, 2022 | CORRESP | |
29 Apr, 2022 | UPLOAD | |
27 Apr, 2022 | DEF 14A | |
27 Apr, 2022 | S-3 | |
27 Apr, 2022 | DEFA14A | |
31 Mar, 2022 | SC 13D | |
22 Mar, 2022 | 4 | |
22 Mar, 2022 | 8-K | |
22 Mar, 2022 | 4 | |
18 Mar, 2022 | 4 | |
10 Mar, 2022 | 10-K | |
10 Mar, 2022 | S-8 | |
10 Mar, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G | |
9 Feb, 2022 | SC 13G | |
9 Feb, 2022 | SC 13G | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
2 Feb, 2022 | 4 | |
9 Nov, 2021 | 10-Q | |
9 Nov, 2021 | 8-K | |
4 Oct, 2021 | 4 | |
20 Sep, 2021 | 3 | |
2 Sep, 2021 | 4 | |
20 Aug, 2021 | 8-K | |
17 Aug, 2021 | 3 | |
9 Aug, 2021 | 10-Q | |
9 Aug, 2021 | 8-K | |
6 Aug, 2021 | 8-K | |
16 Jun, 2021 | 4 | |
16 Jun, 2021 | 3 | |
16 Jun, 2021 | 4 | |
16 Jun, 2021 | 3 | |
7 Jun, 2021 | 8-K | |
10 May, 2021 | 10-Q | |
10 May, 2021 | 8-K | |
9 Apr, 2021 | SC 13G | |
9 Apr, 2021 | SC 13D | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
30 Mar, 2021 | 8-K | |
30 Mar, 2021 | 3/A | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
29 Mar, 2021 | 4 | |
26 Mar, 2021 | 424B4 | IPO completed |
26 Mar, 2021 | S-8 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | EFFECT | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
25 Mar, 2021 | 3 | |
24 Mar, 2021 | SEC STAFF | |
24 Mar, 2021 | CERT | |
23 Mar, 2021 | CORRESP | |
23 Mar, 2021 | 8-A12B | |
23 Mar, 2021 | CORRESP | |
22 Mar, 2021 | S-1/A | |
22 Mar, 2021 | CORRESP | |
18 Mar, 2021 | UPLOAD | |
16 Mar, 2021 | CORRESP | |
5 Mar, 2021 | CORRESP | |
5 Mar, 2021 | S-1 | |
23 Feb, 2021 | SEC STAFF | |
23 Feb, 2021 | UPLOAD | |
12 Feb, 2021 | D | |
26 Jan, 2021 | DRS |
Last update:2024-03-06 13:36:41.703102
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.